Estimation of Cell Survival by Flow Cytometric Quantification of Fluorescein Diacetate/Propidium Iodide Viable Cell Number 1

Cancer Research

Volumn 49, Issue 14, 1989, Pages 3776-3782

  Ross, Douglas D ^a   Joneckis, Christopher C ^a   Ordonez, Jose V ^a   Sisk, Allison M ^a   Wu, Richard K ^a   Hamburger, Anne W ^a   Nora, Richard E ^a  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; FLUORESCEIN DIACETATE; PROPIDIUM IODIDE; VINCRISTINE;

ANIMAL CELL; CELL CULTURE; CELL VIABILITY; CYTOCHEMISTRY; HUMAN; HUMAN CELL; METHODOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL COUNT; CELL CYCLE; CELL LINE; CELL SURVIVAL; DACTINOMYCIN; DAUNORUBICIN; FLOW CYTOMETRY; FLUORESCEINS; HUMAN; INDICATORS AND REAGENTS; PROPIDIUM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR STEM CELL ASSAY; VINCRISTINE;

EID: 0024308082     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Marie, J-P., Zittoin, R., Delmer, A., Thevenin, D., and Suberville, A-M. Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia. Leukemia, 1: 121-126,1987.
2. Griffen, J. D., and Lowenberg, B. Clonogenic cells in acute myeloid leukemia. Blood, 68: 1185-1195, 1986.
3. Kubota, K., Preisler, H. D., Sagawa, K., and Minowada, J. Comparison between agar and methylcellulose cultures of human leukemic cells. Cancer Res., 41: 3052-3057, 1981.
4. Mossman T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
5. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47:936-942, 1987.
6. Gustavsson, A., and Olofsson, T. Prediction of response to chemotherapy in acute leukemia by in vitro-drug sensitivity testing on leukemic stem cells. Cancer Res 44’ 4648-4652 1984
7. Dow, L. W.’, Dahl, G. V., Kalwinsky, D. K., Mirro, J., Nash, M. B., and Roberson, P. K. Correlation of drug sensitivity in-vitro with clinical responses in childhood acute myeloid leukemia. Blood, 68:400-405, 1986.
8. Ross, D. D., Akman, S. A., Joneckis, C. C., Yang, E., and Bachur, N. R. Schedule-dependent enhancement of 1-0-D-arabinofuranosyIcytosine incorporation into DNA by deoxyguanosine. Cancer Res., 44: 1530-1535, 1984.
9. Johnson, R. K., Chitnis, M. P., Embrey, W. M., and Gregory, E. B. In-vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat. Rep., 62: 1535-1547, 1978.
10. Ross, D. D., Joneckis, C. C., and Schiffer, C. A. Effects of verapamil on in-vitro intracellular accumulation and retention of daunorubicin in blast cells from patients with acute nonlymphocytic leukemia. Blood, 68: 83-88, 1986.
11. Dulbecco, R., and Vogt, M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J. Exp. Med., 99: 167-182, 1954.
12. Ross, D. D., Thompson, B. W., Joneckis, C. C., Akman, S. A., and Schiffer, C. A. Metabolism of ara-C by blast cells from patients with ANLL. Blood, 68: 76-82, 1986.
13. Rotman, B., and Papermaster, B. W. Membrane properties of living cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc. Natl. Acad. Sci. USA, 55: 134-141, 1966.
14. Shapiro, H. M. Practical Flow Cytometry, Ed. 1. New York: Alan R. Liss Inc., 1985.
15. Jones, K. H., and Senft, J. A. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J. Histochem. Cytochem., 33:77-79, 1985.
16. Tsuruo, T., lida, H., Yamashiro, H., Tsukagoshi, S., and Sakurai, Y. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin. Biochem. Pharmacol., 31: 3138-3140, 1982.
17. Major, P. P., Egan, E. M., Beardsley, G. P., Minden, M. D., and Kufe, D. W. Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA. Proc. Natl. Acad. Sci. USA, 78: 3235-3239, 1981.
18. Ross, D. D., Thompson, B. W., Joneckis, C. C., Akman, S. A., and Schiffer, C. A. Studies of ara-C metabolism in acute leukemia. Sem. Oncol., 14:182—191, 1987.
19. Prosperi, E., Croce, A. C., Bottiroli, G., and Supino, R. Influence of daunorubicin on membrane permeability properties: detection by means of intracellular accumulation and efflux of fluorescein. Chem.-Biol. Interact., 54: 271-280, 1985.
20. Funa, K., Dawson, N., Jewett, P. B., Agren, H., Ruckdeschel, J. C., Bunn, P. A., Jr., and Gazdar, A. F. Automated fluorescent analysis for drug-induced cytotoxic assays. Cancer Treat. Rep., 70: 1147-1151,1986.
21. Weisenthal, L. M., Dill, P. L., Kumick, N. B., and Lipman, M. E. Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res., 43: 258-264, 1983.
22. Weisenthal, L. M., Marsden, J. A., Dill, P. L., and Macaluso, C. K. A novel dye exclusion for testing in-vitro chemosensitivity of human tumors. Cancer Res., 43: 749-759, 1983.
23. Ellwart, J. W., Kremer, J-P., and Dormer, P. Drug testing in established cell lines by flow cytometric vitality measurements versus clonogenic assay. Cancer Res., 48:5722-5725, 1988.
24. Miyauchi, J., Kelleher, C. A., Yang, Y-C., Wong, G. G., Clark, S. C., Minden, M. D., Minkin, S., and McCulloch, E. A. The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood, 70:657-663, 1987.